532649
Nectar Lifesciences Ltd
BSELast Traded Price
₹12.47
-0.64 (-4.88%)
Open
₹13.11
High
₹13.11
Low
₹12.46
Prev Close
₹13.11
Industry
Healthcare
Market Cap
242.24 Cr
Filing History
Recent corporate announcements and filings for 532649
Governance
Neutral
2026-08-22 14:34
- Nectar Lifesciences Ltd. announced its 31st Annual General Meeting (AGM) for the financial year 2025-26.
- The AGM is scheduled for Friday, September 18, 2026, at 11:00 A.M. IST, to be held via video conference/other audio-visual means.
- Remote e-voting will commence on September 15, 2026 (9:00 A.M. IST) and conclude on September 17, 2026 (5:00 P.M. IST).
- The Annual Report 2025-26 and AGM Notice are available on the company's website and stock exchange websites.
Business Update
Neutral
2026-08-15 11:40
- Nectar Lifesciences Ltd. approved changing its corporate office from Plot No. 110 to Godrej Eternia, Plot No. 70, Industrial Area, Phase-1, Chandigarh.
- The change is effective from September 15, 2026.
Financials
Negative
2026-08-14 20:50
CRITICAL RED FLAG DETECTED
- Q1 FY27 Consolidated Total Income ₹336.20 Lakhs vs ₹30.94 Lakhs (▲986.75% YoY)
- EBITDA (₹2,435.20) Lakhs vs ₹22.21 Lakhs (▼11064.30% YoY)
- PAT (₹1,571.87) Lakhs vs ₹8.81 Lakhs (▼17887.28% YoY)
- EBITDA Margin -724.33% vs 71.79% (▼79612 bps)
- The auditors issued a qualified opinion on consolidated financial results as interim financial information of a subsidiary was not reviewed by their auditors.
- Dr. Gunmala Suri was appointed as an Additional Non-Executive Non-Independent Director.
- The 31st Annual General Meeting (AGM) is scheduled for September 18, 2026.
Governance
Neutral
2026-08-10 20:46
- Notice of Board Meeting of Nectar Lifesciences Ltd. to be held on August 14, 2026.
- The Board will consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026.
Governance
Negative
2026-08-06 18:19
CRITICAL RED FLAG DETECTED
- Dr. Surulichamy Senthilkumar has resigned as a Non-Executive Non-Independent Director of Nectar Lifesciences Limited, effective from the closing hours of August 06, 2026, due to pre-occupations and other personal reasons.
Business Update
Positive
2026-08-04 23:45
- Nectar Lifesciences Ltd. sold the leasehold rights and plant & machinery of its inoperative, non-core unit, Narbada Industries, in Jammu.
- The total consideration received is INR 9,60,00,000/- for leasehold rights and INR 1,62,00,000/- for plant & machinery.
- The purchaser is M/s. Shree Balaji Cold Chain & Storage Services.
Business Update
Neutral
2026-07-23 17:11
- Nectar Lifesciences Ltd. and Capnest Health Care Private Limited have mutually agreed to extend the completion date for the slump sale of the Empty Hard Gelatin Capsule business.
- The new expected completion date is on or before December 31, 2026.
Routine
Neutral
2026-07-11 20:39
- The Board of Directors approved the shifting of the Company's Registered Office within the local limits of Dera Bassi, Punjab.
- The new registered office will be Showroom no. 8, First Floor, Patiala Complex, Barwala Road, Dera Bassi.
- The change is effective from July 15, 2026.
- The Company stated that this change does not affect its operations or any other statutory registrations.
Routine
Neutral
2026-06-24 18:30
- Trading window for designated persons and their immediate relatives to close from July 01, 2026.
- Closure is until 48 hours after financial results for the quarter ended June 30, 2026, are declared, as per SEBI regulations.